Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. - Wikidata - wikimedia - TriplyDB

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

http://www.wikidata.org/entity/Q53417183

about

Cactus pear: a natural product in cancer chemoprevention Drugs for preventing lung cancer in healthy people Drugs for preventing lung cancer in healthy people Transforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system.Breast cancer chemoprevention: beyond tamoxifen Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy Molecular cancer prevention: Current status and future directions Breast cancer chemoprevention: old and new approaches Retinoids induce cellular senescence in breast cancer cells by RAR-β dependent and independent pathways: Potential clinical implications (Review)Medical prevention of breast cancer Familiar drugs may prevent cancer Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer 4-oxo-N-(4-hydroxyphenyl)retinamide: two independent ways to kill cancer cells Solid phase-assisted synthesis and screening of a small library of N-(4-hydroxyphenyl)retinamide (4-HPR) analogs.Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium Trial.Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug.Tamoxifen prevention of breast cancer: an instance of the fingerpost.Prevention of ER-negative breast cancer A short-term rat mammary carcinogenesis model for the prevention of hormonally responsive and nonresponsive in situ carcinomas.Retinoids in chemoprevention and differentiation therapy.Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model High-dose fenretinide in oral leukoplakia.Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations.Diet and breast cancer.Breast cancer and sex steroids: critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer.The CLN9 protein, a regulator of dihydroceramide synthase.Clinical management of women with genomic BRCA1 and BRCA2 mutations.Cyclin proteolysis as a retinoid cancer prevention mechanism.Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention.Prospects for chemoprevention of cancer.Synthesis and preliminary chemotherapeutic evaluation of the fully C-linked glucuronide of N-(4-hydroxyphenyl)retinamide.The bioactive lipid 4-hydroxyphenyl retinamide inhibits flavivirus replication Retinoids, retinoic acid receptors, and breast cancer.Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposure In vitro activities of novel 4-HPR derivatives on a panel of rhabdoid and other tumor cell lines.Modified fatty acids and their possible therapeutic targets in malignant diseases.Fenretinide: a prototype cancer prevention drug.Role of traditional and new biomarkers in breast carcinogenesis.

P2860

Q21245909-294227B4-F2BA-4E42-98A6-3BABD2908D98 Q24198265-794AC738-E628-4B67-8845-F992EA5CFEE4 Q24248776-B2D080FE-E545-4588-BA60-B959BDF42F64 Q24791032-8CB90410-8C2C-4F83-8DCE-DFB980A02A26 Q24793429-53F1DF08-67D2-4AE4-A99A-4FA864B2DC9D Q24803990-ADBE05AD-4FE5-4B73-8FFF-3659C3B25D71 Q26797207-92A2E6A5-50F5-4F28-996B-24D0952DA7E2 Q27693259-01EF7303-194B-4EBA-B081-373767ADA7E7 Q28081010-4A5C7B87-674B-44BE-9CF1-0A12562EAA1D Q28086915-41091DB2-891B-4DA0-BFE9-A4F3AE7EBFF1 Q28186835-419616AF-AA6F-4E01-A586-1739184EF681 Q28366043-80E62BD3-0FA8-4311-AECE-D3A4AAEC24A9 Q28366565-FE864C26-143C-432E-B645-6C22BF24FB21 Q28475774-C32B5B47-726A-4ED1-A8D2-6B12EB37B11E Q33263984-39C22386-D292-4D9D-AB0B-AA31929C495F Q33441111-56BE628E-64EE-477C-B6FE-D7AE1664F52E Q33739214-B3662922-C7CF-4986-822E-F21999E4DD86 Q33765698-44BF3B88-B124-4CC1-95C2-768EFDB573BF Q33796968-459525E1-9F2C-4ABB-97D5-5CD5FD9266B9 Q33897264-784E07BD-2CF7-49A1-9350-43A79C54BFBE Q33954693-87D41F78-5598-4EC7-BBDD-733572A6D11C Q34104057-1DD28AC5-11F1-4BF5-B84C-EF52D916562C Q34164825-304D85A1-F27F-42A6-83F7-BD56BA867C1B Q34173557-A5B5561F-C495-4353-B871-165497F9964B Q34249716-A73D5CD3-5AE2-46B4-8897-008F11484AA5 Q34434006-89FAE32B-F5C7-42F5-9CFA-A7569ECAC2BF Q34469580-AEDB4148-7904-4017-976A-01DDDBE277DA Q34472527-F70E6F88-C1A9-4A23-9870-FE1DAEF7AF8F Q34497372-37359230-9F89-4495-ABB1-01A50A40BA98 Q34497398-B6FD6538-0EFA-4053-934C-F0725B181AEF Q34580753-3569F400-4035-41C3-8F52-07C1E86B8CB1 Q34600760-ED249908-E0BE-4401-8F64-7797793AB290 Q34601105-A5C68886-E823-4B8D-96AC-1BEC92B1254D Q34923354-BA41B7DE-B6AA-468A-83E5-A3DC9B971966 Q35126275-C92DEE8D-789A-4CB8-8514-E30DB0DFCE85 Q35130547-37CA5797-426E-4967-8BC6-A1E14C7CADE4 Q35477972-AB760036-FC1F-4CD8-8C4E-BF1654E3A7D5 Q35537914-13915363-CB7B-4A77-96C3-8E6A21E74AC4 Q35570960-F72F41D3-1EF6-4C5E-878B-8D7942ABF74E Q35572905-671C98B3-8966-4219-8C68-21CCF4E3C1AD

P2860

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

http://www.wikidata.org/entity/Q53417183

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh-hant

name

Randomized trial of fenretinid ...... omen with early breast cancer.

@en

Randomized trial of fenretinid ...... omen with early breast cancer.

@nl

type

label

Randomized trial of fenretinid ...... omen with early breast cancer.

@en

Randomized trial of fenretinid ...... omen with early breast cancer.

@nl

prefLabel

Randomized trial of fenretinid ...... omen with early breast cancer.

@en

Randomized trial of fenretinid ...... omen with early breast cancer.

@nl

P1433

Q53417183-D1BC4DDE-D9C9-45F4-B66C-6498F3EEEF19

P1476

Q53417183-8A870AB7-C7EA-4381-8719-24840AB78E15

P2093

Q53417183-0370490B-7DA2-4B80-8884-DDDF676DAD94

Q53417183-039E14F2-3DB4-4698-B076-63F9CBE07A19

Q53417183-16D9CA95-DE19-4AF0-AA6E-F0431FDB8567

Q53417183-21512275-80A1-4A56-9C8A-CA18DC568D60

Q53417183-30A0D3B7-3E1F-483A-B3E1-A9E89D1D3009

Q53417183-30DDFA00-4F90-4E88-98A5-086355D1AE68

Q53417183-6CA4333B-0DBE-4A33-A86C-0FA13E524057

Q53417183-8641BEB1-B85D-4E60-B71C-F0D3AE142B17

Q53417183-973D442C-DACC-46F0-92A6-D4B89DC87AF1

Q53417183-976CADB4-5761-4180-9C84-0D5142C36568

P304

Q53417183-35BC60D3-7693-47E3-BED0-42CB4C4FCEB3

P31

Q53417183-B4C0EA3A-34CF-44DB-8BEF-939272019079

P356

Q53417183-A19DFE88-976B-4978-872D-F75440461050

P407

Q53417183-D9DE3E8C-BC70-404C-88D4-C3F034FB4712

P433

Q53417183-63A2DA1A-2825-411F-84A9-58D7B7D16072

P478

Q53417183-9A383939-D86B-48C5-9EEE-8E86E9A34C12

P577

Q53417183-C300825C-78E2-4883-A2FC-011396A9F4F0

P5875

Q53417183-327179BB-DEA0-4464-A290-B32BCC6F0B97

P698

Q53417183-75BCBA79-39AA-4C35-87A7-69C7E18FA00F

P356

P1433

Journal of the National Cancer Institute

P1476

Randomized trial of fenretinid ...... omen with early breast cancer.

@en

P2093

Boni C

http://www.w3.org/2001/XMLSchema#string

Camerini T

http://www.w3.org/2001/XMLSchema#string

Campa T

http://www.w3.org/2001/XMLSchema#string

Costa A

http://www.w3.org/2001/XMLSchema#string

D'Aiuto G

http://www.w3.org/2001/XMLSchema#string

De Palo G

http://www.w3.org/2001/XMLSchema#string

Decensi A

http://www.w3.org/2001/XMLSchema#string

Del Turco MR

http://www.w3.org/2001/XMLSchema#string

Del Vecchio M

http://www.w3.org/2001/XMLSchema#string

Di Mauro MG

http://www.w3.org/2001/XMLSchema#string

P304

1847-1856

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/91.21.1847

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

1999-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12754225

http://www.w3.org/2001/XMLSchema#string

P698

10547391

http://www.w3.org/2001/XMLSchema#string